CORDIS call2020

H2020-JTI-IMI2-2020-23-two-stage

H2020-JTI-IMI2-2020-23-two-stage

Programme
H2020
Funded projects (dataset)
6
EU contribution (sum)
€47,787,469
Portal deadline

Leading topic in historical projects: IMI2-2020-23-01

Start here

Suggested partners for this call

Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.

Top coordinators

Organisations that coordinated the most funded projects under this call.

Organisations strong on this topic

Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).

Frequent collaborators

Pairs that often appear together in the same funded project under this call.

Proposal partner finder

One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.

Typical consortium pattern

Derived from historical funded projects linked to this CORDIS call in Grantibase.

Avg. orgs / project
32.5
Median orgs / project
31.5
Min / max orgs
2041

Country presence

Participant rows (an org can appear in multiple countries if data varies).

  • Germany25
  • Switzerland19
  • Netherlands19
  • United Kingdom18
  • Spain16
  • France16
  • Italy14
  • Belgium12
  • Sweden8
  • Austria7
  • Denmark6
  • Portugal5
  • Luxembourg5
  • United States4
  • Ireland3
  • Bulgaria2
  • Norway2
  • Israel2

Organization types

  • company39 orgs · 58 rows
  • university48 orgs · 53 rows
  • research_institute33 orgs · 34 rows
  • sme24 orgs · 24 rows
  • other19 orgs · 20 rows
  • public_body6 orgs · 6 rows

Topics in funded projects

Related funded projects

Largest EU contributions in this call — useful to see who already won funding on similar lines.

Open full project list in advanced search

ProjectEU contribution
SCREEN4CARE

Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies

€11,938,569
OPTIMA

Optimal treatment for patients with solid tumours in Europe through Artificial intelligence

€10,459,997
EPND

European platform for neurodegenerative disorders

€9,680,000
PrIMAVeRa

Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance

€6,500,000
BEAMER

BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

€5,948,903
FACILITATE

FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem

€3,260,000